SOURCE: eLocity Inc.

April 11, 2006 07:10 ET

Tuesday, April 11th Stock Trading Alert

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by eLocity.

SARASOTA, FL -- (MARKET WIRE) -- April 11, 2006 -- eLocity's stocks to watch for today are -- Cryobanks International (OTC BB: BTEM), Nutrition 21, Inc., (NASDAQ: NXXI), MedImmune Inc. (NASDAQ: MEDI), OraLabs Holding Corp. (NASDAQ: OLAB):

Investors, have a look at Cryobanks International (OTC BB: BTEM), a pioneer in collection, isolation and storage technologies for cord blood stem cells. Cryobanks International was the first and is still the only company in the country to accept cord blood donations year round from anywhere in the continental United States.

Monday, after the closing bell, Cryobanks International announced that the company has completed a full Spanish translation of its highly praised informational website, initially launched last October. The Internet site, which is 100% fully translated, is considered a fundamental component in educating the Hispanic population and increasing minority cord blood donations. Although Hispanics represent 12.5% of the population, they represent only 7% of the donor pool in the National Bone Marrow Donor program, leaving the Hispanic community 37% underrepresented.

Cryobanks said that the company expects to receive a significant portion of the $79 million appropriated by the National Cord Blood Act, passed in 2005, for its participation in building the national data bank. The company's Spanish enabled website will be key in informing potential Hispanic donors on how they can participate, Cryobanks said.

Cryobanks International (OTC BB: BTEM) is currently trading at around $4.10 a share.

Other stocks to watch:

Nutrition 21, Inc., (NASDAQ: NXXI) announced Monday that the company has received a purchase order from a national retail chain for its Chromax® chromium picolinate product, and said the purchasing company has requested that its name not be announced until the product is available at all of its over 5,000 stores.

NXXI closed Monday's regular trading session at $2.60.

MedImmune Inc. (NASDAQ: MEDI) announced Monday that preclinical and clinical data showed that Abegrin, a monoclonal antibody that targets the alpha-v beta-3 integrin, may provide a three pronged approach to treat solid tumors.

MEDI closed Monday's regular trading session at $34.16.

Shares of OraLabs Holding Corp. (NASDAQ: OLAB) surged $2.15, or 37.39% Monday. Last week the company announced that it had entered into a definitive Stock Exchange Agreement with Partner Success Holdings Ltd., where it will acquire all the issued and outstanding shares of Partner Success Holdings in exchange for 94% of the issued and outstanding shares of OraLabs'common stock on a fully diluted basis.

OLAB closed Monday's regular trading session at $7.90.

About eLocity Inc: eLocity owns and operates three financial websites for investors., Featuring active message boards for the penny stock trader, rumors and more., Visit this site for our daily top stock "GRID Makers." We rank stocks on volume, message board activity, sentiment and trend forecast., Bell2Bell features news stories, rumors, the InvestBoard and more.

Sign up for FREE at any of the sites above.

The newsletter is provided by eLocity Inc., an electronic broadcaster and publisher of this newsletter, is here after referred to as "the company." The company received compensation for this service for BTEM (Public Company). The compensation is one thousand, two hundred dollars from a non-affiliated third party, Equity Alliance, Inc. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.

The company reserves the right to trade in securities mentioned herein, and may make purchases or sales in such securities featured within our newsletter reports. The information contained in this publication is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. All statements of opinions, if any, (Our Summary) are those of the company.

The company relies exclusively on information gathered on the Public Company, such as public filings, press releases and its web sites. Investors should use the information contained in this publication as a starting point for conducting additional research on the Public Company in order to allow the investor to form his or her own opinion regarding the Public Company. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer.

Investing in the Public Company that this newsletter is providing service for should be reviewed is speculative and a high-risk and may result in the loss of some or all of any investment made in the client. This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended.

The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.

Contact Information

  • Contact:
    eLocity Inc.
    Thomas Clay